Market Cap: $752.51M
CI
Cryoport, Inc.
CYRX
NASDAQ (NASDAQ Capital Market)USD
Market Cap: $752.51M
CryoPort, Inc. (Ticker: CYRX) strengthens its position in the life sciences sector through its recent collaboration with Verismo Therapeutics. The partnership focuses on CryoPort’s IntegriCell® cryopr…
CryoPort Sees Strong Revenue Growth Driven by Demand for Temperature-Controlled Supply Chain Solutions CryoPort, Inc. demonstrates robust growth in its recent Q4 earnings report, highlighting a 25% ye…
### CryoPort’s Q4 Earnings Showcase Robust Growth and Strategic Investments CryoPort, Inc. reports a remarkable performance in its Q4 earnings for 2026, with a significant revenue growth of 25% year-o…
CryoPort Prepares for Key Earnings Announcement Amidst Biopharmaceutical Sector Growth As CryoPort approaches its quarterly earnings announcement scheduled for March 3, 2026, stakeholders are keenly a…
CryoPort Prepares for Impactful Earnings Release Amid Biopharmaceutical Growth As CryoPort approaches its scheduled quarterly earnings announcement on March 3, 2026, anticipation builds around the com…
Cryoport unveils door‑friendly LN₂‑free freezer Fusion 800 frees clinics and labs from liquid nitrogen infrastructure Cryoport’s MVE Biological Solutions unit is rolling out the MVE Fusion 800 Series,…
CryoPort's Role in the Evolving Biologics Supply Chain In the current landscape of biologics and temperature-sensitive shipments, CryoPort is at the forefront of ensuring that critical biological mate…
Cryoport Achieves Groundbreaking ISO Certification in Temperature-Controlled Supply Chain Solutions Cryoport, Inc., a frontrunner in temperature-controlled supply chain solutions for the life sciences…
Cryoport Achieves Groundbreaking ISO Certification for Cell Therapy Transport Cryoport, Inc. (NASDAQ: CYRX), a frontrunner in temperature-controlled supply chain solutions for the life sciences, proud…
CryoPort Unveils Cutting-Edge Condition Monitoring Solutions for Life Sciences CryoPort, Inc. announces the launch of MVE Biological Solutions' integrated Condition Monitoring Solutions, specifically…
CryoPort Expands European Presence with New Facility in France CryoPort, Inc. announces the opening of its new 55,000-square-foot facility in Louvres, France, through its subsidiary Cryoport Systems.…
CryoPort Navigates a Complex Landscape in Biopharmaceutical Logistics In the biopharmaceutical logistics sector, CryoPort, Inc. (CYRX) currently faces a dynamic environment characterized by a mix of b…
CryoPort Faces Mixed Analyst Sentiment Amid Industry Growth In the biopharmaceutical logistics sector, CryoPort, Inc. (CYRX) stands at a pivotal point as analysts express a spectrum of opinions regard…
CryoPort Expands Its Global Cold Chain Logistics for Biopharmaceuticals CryoPort, a key player in the cold chain logistics sector for biopharmaceuticals, announces a significant expansion of its globa…
CryoPort Unveils Innovative Vapor Shippers to Enhance Biologics Transport CryoPort, Inc. (CYRX) announces the launch of two new vapor shippers, the SC 4/2V and SC 4/3V models, specifically engineered…
CryoPort's Strategic Positioning in the Cell and Gene Therapy Market UBS's recent upgrade of CryoPort, elevating its rating from neutral to buy, signals a renewed confidence in the company's potential…